Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee
Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee
Active, not recruiting · NCT04119687 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Phase 1 | 2026-09-17 | NCT04119687 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pacira Pharmaceuticals, Inc | 17 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Altoona Center for Clinical Research | Duncansville | United States | 32 |
| Arizona Research Center | Phoenix | United States | 12 |
| Center for Pharmaceutical Research | Kansas City | United States | 1 |
| Gulfcoast Research Institute, LLC | Sarasota | United States | 1 |
| Metroplex Clinical Research Center | Dallas | United States | 2 |
| University Orthopedics Center | Altoona | United States | 5 |